Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Idelalisib 150 / Rituximab 500, Chronic Lymphocytic Leukemia, cycle 2-5

Protocol-ID: 330 V1.3 (Mini), IDEL150/RITU500, CLL C2-5

Indication(s)

  • Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 21.12.2023